CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 21 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $489,000 | -20.0% | 328,030 | +13.9% | 0.06% | -34.5% |
| Q3 2017 | $611,000 | +49.4% | 288,030 | 0.0% | 0.09% | +26.1% |
| Q2 2017 | $409,000 | -34.1% | 288,030 | -25.8% | 0.07% | -43.0% |
| Q1 2017 | $621,000 | -55.6% | 388,030 | +0.0% | 0.12% | -65.8% |
| Q4 2016 | $1,400,000 | -41.4% | 387,943 | 0.0% | 0.35% | -9.0% |
| Q3 2016 | $2,390,000 | +217.8% | 387,943 | +90.9% | 0.39% | +99.5% |
| Q2 2016 | $752,000 | -35.1% | 203,243 | -11.6% | 0.20% | -22.3% |
| Q1 2016 | $1,159,000 | +81.1% | 230,041 | +184.9% | 0.25% | +167.0% |
| Q4 2015 | $640,000 | -75.3% | 80,742 | -75.3% | 0.09% | -71.6% |
| Q3 2015 | $2,595,000 | -48.7% | 327,476 | -26.6% | 0.33% | -33.3% |
| Q2 2015 | $5,060,000 | – | 446,036 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $23,118,000 | 12.93% |
| Clarus Ventures, LLC | 2,752,488 | $22,268,000 | 12.81% |
| Camber Capital Management LP | 1,000,000 | $8,090,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 300,427 | $2,430,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 327,476 | $2,595,000 | 0.33% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 628,482 | $5,084,000 | 0.20% |
| Spark Investment Management LLC | 32,500 | $263,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 10,764 | $87,000 | 0.01% |
| VANGUARD GROUP INC | 4,732,472 | $168,937,000 | 0.01% |
| Alyeska Investment Group, L.P. | 40,220 | $325,000 | 0.00% |